EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Date

Title

File

Times

2023-08-22

NEXT DAY DISCLOSURE RETURN

681

2023-08-21

NEXT DAY DISCLOSURE RETURN

720

2023-08-18

NEXT DAY DISCLOSURE RETURN

700

2023-08-17

NEXT DAY DISCLOSURE RETURN

704

2023-08-16

INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2023

738

2023-08-16

INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023

733

2023-08-04

NOTICE OF BOARD MEETING

755

2023-08-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2023

676

2023-07-26

VOLUNTARY ANNOUNCEMENT UPDATE ON THE PHASE 1/2 CLINICAL STUDY IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS FOR THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

718

2023-07-21

NEXT DAY DISCLOSURE RETURN

743

2023-07-17

VOLUNTARY ANNOUNCEMENT EARLY REPAYMENT OF LOAN FACILITY

819

2023-07-14

NEXT DAY DISCLOSURE RETURN

802

2023-07-10

NEXT DAY DISCLOSURE RETURN

782

2023-07-06

NEXT DAY DISCLOSURE RETURN

786

2023-07-05

NEXT DAY DISCLOSURE RETURN

804

2023-07-04

NEXT DAY DISCLOSURE RETURN

756

2023-07-04

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2023

771

2023-06-29

NEXT DAY DISCLOSURE RETURN

755

2023-06-23

NEXT DAY DISCLOSURE RETURN

862

2023-06-21

NEXT DAY DISCLOSURE RETURN

777

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT